Esophageal cancer risk test developer gets new funding

A molecular diagnostic testing company has received $55,000 from a Pennsylvania economic development agency to develop a test to determine a patient’s risk for esophageal cancer if they have Barrett’s esophagus. The company is collaborating with Geisinger Health System on the test. Ben Franklin Technology Partners of Northeastern Pennsylvania has invested a total of $100,000 […]


Pathology imaging firm Cernostics pulls in $2.6M

Slightly under-the-radar Cernostics Inc. has raised $2.6 million in equity, debt and options, according to a regulatory filing with the Securities and Exchange Commission. The newly rechristened Cernostics was previously known as Cernostics Pathology Inc., including in 2008 when it was spun off from Pittsburgh-based Cellumen Inc. At the time of the spinoff, Cernostics’ aim […]